1,414
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel

, , , , , & ORCID Icon show all
Pages 2527-2532 | Received 16 Jan 2018, Accepted 03 May 2018, Published online: 06 Sep 2018

References

  • Angoulvant F, Levy C, Grimprel E, Varon E, Lorrot M, Biscardi S, Minodier P, Dommergues MA, Hees L, Gillet Y, et al. Early impact of 13-Valent Pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis. 2014;58(7):918–24. doi:10.1093/cid/ciu006. PMID:24532543.
  • Chan CHS, Cohen M, Pang J. A Prospective Study of Community-Acquired Pneumonia in Hong Kong. Chest. 1992;101(2):442–6. doi:10.1378/chest.101.2.442. PMID:1735270.
  • File TM, Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgraduate Med. 2010;122(2):130–41. doi:10.3810/pgm.2010.03.2130.
  • Quan TP, Fawcett NJ, Wrightson JM, Finney J, Wyllie D, Jeffery K, Jones N, Shine B, Clarke L, Crook D, et al. Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998–2014. Thorax. 2016;71(6):535–42. doi:10.1136/thoraxjnl-2015-207688. PMID:26888780.
  • Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057–65. doi:10.1136/thoraxjnl-2013-204282. PMID:24130229.
  • File TM, Jr. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am J Med. 2004;117 Suppl 3A:39S–50S. PMID:15360096.
  • Lieberman D, Schlaeffer F, Boldur I, Lieberman D, Horowitz S, Friedman MG, Leiononen M, Horovitz O, Manor E, Porath A. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax. 1996;51(2):179–84. doi:10.1136/thx.51.2.179. PMID:8711652.
  • Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R, Israeli Bacteremia and Meningitis Active Surveillance Group. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine. 2012;30(46):6600–7. doi:10.1016/j.vaccine.2012.08.012. PMID:22939907.
  • Greenberg D, Givon-Lavi N, Ben-Shimol S, Ziv JB, Dagan R. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years. Vaccine. 2015;33(36):4623–9. doi:10.1016/j.vaccine.2015.06.062. PMID:26116251.
  • Regev-Yochay G, Katzir M, Strahilevitz J, Rahav G, Finn T, Miron D, Maor Y, Chazan B, Schindler Y, Dagan R, et al. The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel. Vaccine. 2017;35(18):2449–56. doi:10.1016/j.vaccine.2017.03.031. PMID:28342668.
  • Ben-Shimol S, Givon-Lavi N, Grisaru-Soen G, Megged O, Greenberg D, Dagan R. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies. Vaccine. 2017;(17):30707–7. doi:10.1016/j.vaccine.2017.05.059.
  • Saha S, Darmstadt G, Naheed A, Arifeen S, Islam M, Fatima K, Breiman R, Sack D, Hamer D. Improving the sensitivity of blood culture for Streptococcus pneumoniae. J Trop Pediatr. 2011;57(3):192–6. doi:10.1093/tropej/fmq070. PMID:20736384.
  • Stralin K, Kaltoft MS, Konradsen HB, Olcen P, Holmberg H. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol. 2004;42(8):3620–5. doi:10.1128/JCM.42.8.3620-3625.2004. PMID:15297507.
  • Murdoch DR, Laing RT, Mills GD, Karalus NC, Town GI, Mirrett S, Reller LB. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol. 2001;39(10):3495–8. doi:10.1128/JCM.39.10.3495-3498.2001. PMID:11574562.
  • Ishida T, Hashimoto T, Arita M, Tojo Y, Tachibana H, Jinnai M. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J Infect Chemother. 2004;10(6):359–63. doi:10.1007/s10156-004-0351-1. PMID:15614462.
  • BinaxNow® [package insert]. Scarborough, ME: Alere Scarborough, Inc.; 2012.
  • Pride MW, Huijts SM, Wu K, Souza V, Passador S, Tinder C, Song E, Elfassy A, McNeil L, Menton R, et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vaccine Immunol. 2012;19(8):1131–41. doi:10.1128/CVI.00064-12. PMID:22675155.
  • Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL, AGEDD Adult Pneumococcal Burden Study Team, Andreo F, Beovic B, Blanco S, Boersma WG, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PloS One. 2013;8(4):e60273. doi:10.1371/journal.pone.0060273. PMID:23565216.
  • LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Li L, Ambrose A, Hatchette TF, Lang AL, Gillis H, Martin I, et al. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study. Vaccine. 2017;35(29):3647–54. doi:10.1016/j.vaccine.2017.05.049. PMID:28554501.
  • Harat R, Alexander R, Gray S, Gutterman EM, Pluta J, Pride M, Shite S, Fijolek J, Kozub J. Prospective, population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzanow County, Poland, 2010 to 2012. Pneumonol Alergol Pol. 2016;84(2):95–103. doi:10.5603/PiAP.2016.0007. PMID:27238167.
  • Sherwin RL, Gray S, Alexander R, McGovern PC, Graepel J, Pride MW, Purdy J, Paradiso P, File TM, Jr. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged >/ = 50 years with community-acquired pneumonia. J Infect Dis. 2013;208(11):1813–20. doi:10.1093/infdis/jit506. PMID:24092845.
  • Palmu AA, Kaijalainen T, Saukkoriipi A, Leinonen M, Kilpi TM. Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects. Scandinavian J Infect Dis. 2012;44(6):433–8. doi:10.3109/00365548.2011.652162.
  • Wunderink RG, Self WH, Anderson EJ, Balk R, Fakhran S, Courtney DM, Qi C, Williams DJ, Zhu Y, Whitney CG, et al. Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays. Clin Infect Dis. 2018;66(10):1504–10. doi:10.1093/cid/cix1066. PMID:29342250.
  • Klugman KP, Madhi SA, Albrich WC. Novel Approaches to the Identification of Streptococcus pneumoniae as the Cause of Community-Acquired Pneumonia. Clin Infect Dis. 2008;47(Supplement_3):S202–6. doi:10.1086/591405. PMID:18986290.
  • Musher DM, Alexandraki I, Graviss EA, Yanbeiy N, Eid A, Inderias LA, Phan HM, Solomon E. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore). 2000;79(4):210–21. doi:10.1097/00005792-200007000-00002. PMID:10941350.
  • Werno AM, Murdoch DR. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis. 2008;46(6):926–32. doi:10.1086/528798. PMID:18260752.
  • Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Critical Care Med. 1999;160(2):397–405. doi:10.1164/ajrccm.160.2.9808045.
  • Bandettini R, Melioli G. Laboratory diagnosis of Streptococcus pneumoniae infections: past and future. J Prev Med Hyg. 2012;53(2):85–88. PMID:23240165.
  • Kirkpatrick B, Reeves DS, MacGowan AP. A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect. 1994;29(2):171–82. doi:10.1016/S0163-4453(94)90698-X. PMID:7806880.
  • O'Brien KL, Nohynek H, World Health Organization Pneumococcal Vaccine Trials Carriage Working G. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatric Infect Dis J. 2003;22(2):e1–11. doi:10.1097/01.inf.0000049347.42983.77.
  • Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43(6):699–709. PMID:13297.
  • Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992;14(4):801–7. doi:10.1093/clinids/14.4.801. PMID:1576274.
  • Arai S, Konda T, Wad A, Matsunaga Y, Okabe N, Watanabe H, Inouye S. Use of antiserum-coated latex particles for serotyping Streptococcus pneumoniae. Microbiol Immunol. 2001;45(2):159–62. doi:10.1111/j.1348-0421.2001.tb01284.x. PMID:11293482.
  • Smith MD, Derrington P, Evans R, Creek M, Morris R, Dance DA, Cartwright K. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol. 2003;41(7):2810–3. doi:10.1128/JCM.41.7.2810-2813.2003. PMID:12843005.
  • Leeming JP, Cartwright K, Morris R, Martin SA, Smith MD, South-West Pneumococcus Study G. Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection. J Clin Microbiol. 2005;43(10):4972–6. doi:10.1128/JCM.43.10.4972-4976.2005. PMID:16207950.